|
|
|
Insider
Information: |
Henderson Lori M |
Relationship: |
General Counsel and Se... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
62,896 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
62,896 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Albany Molecular Research Inc |
AMRI |
SVP, Secretary & Gen C... |
2017-03-02 |
61,995 |
|
0 |
Premium* |
|
Moderna, Inc. |
MRNA |
General Counsel and Se... |
2021-05-27 |
901 |
2020-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-02-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,582) |
37,468 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,458) |
35,546 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(464) |
37,004 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-03-02 |
4 |
A |
$17.05 |
$180,525 |
D/D |
10,588 |
46,134 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,459) |
44,199 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen. Counsel |
|
2015-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(476) |
45,658 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2015-11-02 |
4 |
A |
$19.16 |
$95,800 |
D/D |
5,000 |
49,199 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-01-31 |
4 |
D |
$15.97 |
$17,695 |
D/D |
(1,108) |
48,091 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-02-04 |
4 |
D |
$16.16 |
$11,053 |
D/D |
(684) |
47,407 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-02-04 |
4 |
A |
$15.77 |
$199,995 |
D/D |
12,682 |
60,089 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,459) |
58,167 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-02-17 |
4 |
D |
$15.37 |
$7,116 |
D/D |
(463) |
59,626 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-03-02 |
4 |
D |
$15.33 |
$6,454 |
D/D |
(421) |
57,746 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-11-02 |
4 |
D |
$15.09 |
$6,172 |
D/D |
(409) |
57,337 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2016-11-16 |
4 |
S |
$17.00 |
$102,000 |
D/D |
(6,000) |
51,337 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2017-01-31 |
4 |
D |
$18.11 |
$20,030 |
D/D |
(1,106) |
50,231 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2017-02-04 |
4 |
D |
$18.52 |
$65,579 |
D/D |
(3,541) |
46,690 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,737 |
62,427 |
0 |
- |
|
AMRI |
Albany Molecular Research... |
SVP, Secretary & Gen Counsel |
|
2017-03-02 |
4 |
D |
$14.52 |
$6,273 |
D/D |
(432) |
61,995 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-05-20 |
4 |
AS |
$70.00 |
$4,480,000 |
D/D |
(64,000) |
0 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-05-20 |
4 |
OE |
$14.85 |
$950,400 |
D/D |
64,000 |
64,000 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-06-18 |
4 |
AS |
$63.03 |
$4,033,920 |
D/D |
(64,000) |
681 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-06-18 |
4 |
OE |
$14.85 |
$950,400 |
D/D |
64,000 |
64,681 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-10-21 |
4 |
AS |
$68.70 |
$2,245,158 |
D/D |
(32,000) |
681 |
0 |
- |
|
MRNA |
Moderna, Inc. |
General Counsel and Secretary |
|
2020-10-21 |
4 |
OE |
$14.85 |
$475,200 |
D/D |
32,000 |
32,681 |
0 |
- |
|
102 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|